CD8+ T cells are critical components of the anti-viral immune response to viruses. Naive CD8+ T cells differentiate into effectors cells only after recognition of peptide-MHC Class I complexes on the surface of antigen presenting cells (APC). The peptides recognized as part of the peptide-MHC complex can be generated from two spatially distinct sources. Directly presented peptides are generated from protein antigens expressed within a virus-infected pAPC. Alternatively, pAPC that are not infected can present peptides, a process termed cross-priming. Cross-priming requires the transfer of antigen derived from virus-infected cells to pAPC prior to presentation to naive CD8+ T cells. The extent to which direct-priming or cross-priming contribute to activation of naive CD8+ T cells in vivo is not known. The overall objective of this project is to delineate the mechanisms used to generate MHC Class I-peptide complexes during priming of naive CD8+ T cells in vivo. Our underlying hypothesis is that alteration in protein expression or localization can, and does, define the usage of the direct or cross-priming pathways in vivo. To examine this issue we will use recombinant viruses to express multiple protein antigens and will analyze antigen presentation to naive and effector CD8+ T cells both in vitro and in vivo.
In Aim 1 we will explore the mechanisms responsible for a novel mode of immune evasion in which late vaccinia virus antigens are prevented from entering the cross presentation pathway.
In Aim 2 we will examine the mechanisms responsible for prolonged MHC Class I-restricted antigen presentation following clearance of virus, a prerequisite for optimal entry of CD8+ T cells in the memory phase of the response. We will examine the contribution of the direct and cross presentation pathways to the persistence of antigen presentation, and examine how a short-lived population of antigen presenting cells can present antigen for extended periods of time.
In Aim 3 we will use a unique system to examine the efficiency of direct presentation by different cell types, and by cell types at various stages of maturation. In addition, we will definitely outline the role of direct and cross presentation in initiation of CD8+ T cell responses. Delineation of the mechanisms governing the use of different antigen presentation pathways in vivo is essential to provide a basis for the rational design of vaccines and immunotherapeutic strategies aimed at induction of protective CD8+ T cells.

Public Health Relevance

A subset of immune cells known as CD8 T cells can provide protection against many virus infections by killing virus-infected cells. Clearly, induction of these CD8 T cells is a desirable outcome of any vaccination strategy. However, currently no vaccine strategies effectively target induction of CD8 T cells, probably because information about the events required to trigger these cells is lacking. Our proposal will investigate the early events in the triggering of CD8 T cells, with a view to gaining knowledge vital for the design of effective antiviral vaccines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI056094-10
Application #
8429471
Study Section
Immunity and Host Defense Study Section (IHD)
Program Officer
Gondre-Lewis, Timothy A
Project Start
2003-09-15
Project End
2014-02-28
Budget Start
2013-03-01
Budget End
2014-02-28
Support Year
10
Fiscal Year
2013
Total Cost
$355,667
Indirect Cost
$125,343
Name
Pennsylvania State University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
129348186
City
Hershey
State
PA
Country
United States
Zip Code
17033
Heipertz, Erica L; Davies, Michael L; Lin, Eugene et al. (2014) Prolonged antigen presentation following an acute virus infection requires direct and then cross-presentation. J Immunol 193:4169-77
Hunzeker, John T; Elftman, Michael D; Mellinger, Jennifer C et al. (2011) A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells. J Immunol 186:183-94
Fischer, Matthew A; Davies, Michael L; Reider, Irene E et al. (2011) CD11b?, Ly6G? cells produce type I interferon and exhibit tissue protective properties following peripheral virus infection. PLoS Pathog 7:e1002374
Elftman, Michael D; Hunzeker, John T; Mellinger, Jennifer C et al. (2010) Stress-induced glucocorticoids at the earliest stages of herpes simplex virus-1 infection suppress subsequent antiviral immunity, implicating impaired dendritic cell function. J Immunol 184:1867-75
Schell, Amanda M; Granger, Erica L; Koczot, Frank et al. (2010) Dendritic cell migration limits the duration of CD8+ T-cell priming to peripheral viral antigen. J Virol 84:3586-94
Reiley, William W; Jin, Wei; Lee, Andrew Joon et al. (2007) Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. J Exp Med 204:1475-85
Fischer, Matthew A; Tscharke, David C; Donohue, Keri B et al. (2007) Reduction of vector gene expression increases foreign antigen-specific CD8+ T-cell priming. J Gen Virol 88:2378-86
Fischer, Matthew A; Norbury, Christopher C (2007) Initiation of primary anti-vaccinia virus immunity in vivo. Immunol Res 37:113-33
Reiley, William W; Zhang, Minying; Jin, Wei et al. (2006) Regulation of T cell development by the deubiquitinating enzyme CYLD. Nat Immunol 7:411-7
Norbury, Christopher C (2006) Drinking a lot is good for dendritic cells. Immunology 117:443-51

Showing the most recent 10 out of 12 publications